This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Succinylcholine Chloride

Read time: 1 mins
Marketing start date: 23 Nov 2024

Summary of product characteristics


Effective Time

20231019

Version

5

Spl Product Data Elements

Succinylcholine Chloride Succinylcholine Chloride SUCCINYLCHOLINE CHLORIDE SUCCINYLCHOLINE HYDROCHLORIC ACID METHYLPARABEN PROPYLPARABEN SODIUM CHLORIDE SODIUM HYDROXIDE

Application Number

ANDA209467

Brand Name

Succinylcholine Chloride

Generic Name

Succinylcholine Chloride

Product Ndc

70771-1352

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAMUSCULAR,INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Vial Label NDC 70771-1352-1 Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL) For Intravenous or Intramuscular use. 10 mL Multiple-dose Vial Rx only Zydus Pharmaceuticals container-label

Spl Unclassified Section

SPL UNCLASSIFIED

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.